BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28886809)

  • 1. Detection of Genetic Aberrations in the Assessment and Prognosis of Melanoma.
    High WA
    Dermatol Clin; 2017 Oct; 35(4):525-536. PubMed ID: 28886809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Melanoma Diagnosis Update: Gene Fusion, Genomic Hybridization, and Massively Parallel Short-Read Sequencing.
    Lang UE; Yeh I; McCalmont TH
    Clin Lab Med; 2017 Sep; 37(3):473-484. PubMed ID: 28802496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of molecular morphology techniques on the expert diagnosis in melanocytic skin neoplasms.
    Ferrara G; Misciali C; Brenn T; Cerroni L; Kazakov DW; Perasole A; Russo R; Ricci R; Crisman G; Fanti PA; Passarini B; Patrizi A
    Int J Surg Pathol; 2013 Oct; 21(5):483-92. PubMed ID: 23775023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular diagnostics for ambiguous melanocytic tumors.
    Shahbain H; Cooper C; Gerami P
    Semin Cutan Med Surg; 2012 Dec; 31(4):274-8. PubMed ID: 23174498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral heterogeneity of chromosome 9 loss and CDKN2A (p16) protein expression in a morphologically challenging spitzoid melanoma.
    DiSano K; Tschen JA; Cho-Vega JH
    Am J Dermatopathol; 2013 Apr; 35(2):277-80. PubMed ID: 23221484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of New Techniques in Addition to IHC Applied to the Diagnosis of Melanocytic Lesions, With Emphasis on CGH, FISH, and Mass Spectrometry.
    Nagarajan P; Tetzlaff MT; Curry JL; Prieto VG
    Actas Dermosifiliogr; 2017; 108(1):17-30. PubMed ID: 27344067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular diagnosis of melanocytic tumors].
    Bauer J
    Hautarzt; 2016 Jan; 67(1):59-63. PubMed ID: 26589514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difficult to Diagnose Cutaneous Melanoma in a Patient with BAP1 Tumor Predisposition Syndrome.
    Silva-Clavería F; Álvarez-Muñoz A; Ferrándiz L; Fernández-Orland A; Conde-Martin AF; Moreno-Ramírez D; Ríos-Martín JJ
    Int J Surg Pathol; 2023 Oct; 31(7):1398-1402. PubMed ID: 36803128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Profiling in Cutaneous Melanoma.
    Ji AL; Bichakjian CK; Swetter SM
    J Natl Compr Canc Netw; 2016 Apr; 14(4):475-80. PubMed ID: 27059194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence in situ hybridization for the differential diagnosis between Spitz naevus and spitzoid melanoma.
    Requena C; Rubio L; Traves V; Sanmartín O; Nagore E; Llombart B; Serra C; Fernández-Serra A; Botella R; Guillén C
    Histopathology; 2012 Nov; 61(5):899-909. PubMed ID: 22882594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions.
    Harms PW; Hocker TL; Zhao L; Chan MP; Andea AA; Wang M; Harms KL; Wang ML; Carskadon S; Palanisamy N; Fullen DR
    Hum Pathol; 2016 Dec; 58():152-160. PubMed ID: 27569296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic utility of epithelial and melanocitic markers with double sequential immunohistochemical staining in differentiating melanoma in situ from invasive melanoma.
    Parra-Medina R; Morales SD
    Ann Diagn Pathol; 2017 Feb; 26():70-74. PubMed ID: 27594302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What's new in prognostication of melanoma in the dermatopathology laboratory?
    Bangash HK; Romegialli A; Dadras SS
    Clin Dermatol; 2013; 31(3):317-23. PubMed ID: 23608451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical application of new technologies for melanoma diagnosis: Part II. Molecular approaches.
    March J; Hand M; Truong A; Grossman D
    J Am Acad Dermatol; 2015 Jun; 72(6):943-58; quiz 959-60. PubMed ID: 25980999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fluorescence in-situ hybridization as a diagnostic tool for cutaneous melanoma].
    Su J; Liu J; Zheng J; You J; Ma X; Zhang Y; Zhang J; Liao S
    Zhonghua Bing Li Xue Za Zhi; 2015 Jan; 44(1):37-41. PubMed ID: 25765029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic tissue markers in melanoma.
    Moore DA; Pringle JH; Saldanha GS
    Histopathology; 2012 Apr; 60(5):679-89. PubMed ID: 21880059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric "STUMP" lesions: evaluation and management of difficult atypical Spitzoid lesions in children.
    Tom WL; Hsu JW; Eichenfield LF; Friedlander SF
    J Am Acad Dermatol; 2011 Mar; 64(3):559-72. PubMed ID: 21255872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular diagnostic contribution in melanocytic lesions analysis (FISH/CGH)].
    de la Fouchardière A; Vergier B
    Ann Pathol; 2011 Nov; 31(5 Suppl):S115-6. PubMed ID: 22054446
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular techniques for predicting behaviour in melanocytic neoplasms.
    Lee CY; Gerami P
    Pathology; 2016 Feb; 48(2):142-6. PubMed ID: 27020386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular markers in melanoma.
    Kashani-Sabet M
    Br J Dermatol; 2014 Jan; 170(1):31-5. PubMed ID: 23815339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.